Ms. Meredith I Clements, L..P.N. Licensed Vocational Nurse Medicare: Not Enrolled in Medicare Practice Location: 1 Cumberland Pl Ste 108, Bangor, ME 04401 Phone: 207-990-9000 |
News Archive
A clinic in a low-income Milwaukee neighborhood has filled a need for 23 years, but people running it worry that it may not be helped by any changes to the health care system. The New York Times reports on the Milwaukee Immediate Care Center, a small nonprofit clinic, "which keeps hours at night and on weekends, [and] is the only full-time operation in the neighborhood that provides urgent care, luring patients with a sign that reads, 'When You Need a Doctor Today.'"
A team of international scientists has recently revealed that severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) interacts with two heme metabolites, bilirubin and biliverdin, to escape the antibody-mediated host immune responses.
Spectral Diagnostics Inc. and BioMS Medical Corp. today announced that BioMS Medical ("BioMS") and a syndicate of investors have invested $14 million in Spectral Diagnostics ("Spectral", or the "Company") to advance Toraymyxin(TM), a treatment for severe sepsis, towards regulatory approval and commercialization in the United States.
A study published in the open access journal BMC Medicine shows that patients would prefer to receive the same information as their general practitioner (GP) following an outpatient consultation, rather than a letter written especially for them.
The U.S. Food and Drug Administration has approved tetrabenazine, the first drug approved for use in the United States to treat Huntington's disease, a fatal, inherited neurodegenerative disorder for which there is no cure. The action comes about eight months after an advisory panel unanimously voted to advise FDA to make the medication available to treat the disease.
› Verified 4 days ago